| # | Drug | Count |
|---|---|---|
| 0 | INFLIXIMAB | 4 |
| 1 | ADALIMUMAB | 3 |
| 2 | MESALAMINE | 3 |
| 3 | TACROLIMUS | 3 |
| 4 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 3 |
| 5 | TACROLIMUS OINTMENT 0.1% | 3 |
| 6 | ANTACID | 2 |
| 7 | CALCIUM CARBONATE | 2 |
| 8 | FIDAXOMICIN | 2 |
| 9 | IXEKIZUMAB | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | FIDAXOMICIN | 2 | 0.0008 |
| 1 | VANCOMYCIN HYDROCHLORIDE | 2 | 0.0002 |
| 2 | BECLOMETHASONE DIPROPIONATE | 1 | 0.0002 |
| 3 | TOFACITINIB CITRATE | 2 | 0.0001 |
| 4 | MESALAMINE | 3 | 0.0001 |
| 5 | VALGANCICLOVIR | 2 | 0.0001 |
| 6 | MYCOPHENILIC ACID | 2 | 0.0001 |
| 7 | DESLORATADINE | 1 | 0.0001 |
| 8 | MYCOPHENOLIC ACID | 2 | 0.0001 |
| 9 | IXEKIZUMAB | 2 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Macrolide Antibacterial [EPC] | 2 | 0.0020 |
| 1 | Antimetabolite Immunosuppressant [EPC] | 2 | 0.0001 |
| 2 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 2 | 0.0001 |
| 3 | Interleukin-17A Antagonist [EPC] | 2 | 0.0001 |
| 4 | Human Immunoglobulin G [EPC] | 1 | 0.0000 |
| 5 | Glycopeptide Antibacterial [EPC] | 2 | 0.0000 |
| 6 | Nitroimidazole Antimicrobial [EPC] | 2 | 0.0000 |
| 7 | Integrin Receptor Antagonist [EPC] | 2 | 0.0000 |
| 8 | Aminosalicylate [EPC] | 2 | 0.0000 |
| 9 | Histamine-1 Receptor Antagonist [EPC] | 1 | 0.0000 |